Converging global health agendas and universal health coverage: financing whole-of-government action through UHC.


Journal

The Lancet. Global health
ISSN: 2214-109X
Titre abrégé: Lancet Glob Health
Pays: England
ID NLM: 101613665

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 31 05 2023
revised: 14 09 2023
accepted: 10 10 2023
medline: 20 11 2023
pubmed: 17 11 2023
entrez: 16 11 2023
Statut: ppublish

Résumé

UN member states have committed to universal health coverage (UHC) to ensure all individuals and communities receive the health services they need without suffering financial hardship. Although the pursuit of UHC should unify disparate global health challenges, it is too commonly seen as another standalone initiative with a singular focus on the health sector. Despite constituting the cornerstone of the health-related Sustainable Development Goals, UHC-related commitments, actions, and metrics do not engage with the major drivers and determinants of health, such as poverty, gender inequality, discriminatory laws and policies, environment, housing, education, sanitation, and employment. Given that all countries already face multiple competing health priorities, the global UHC agenda should be used to reconcile, rationalise, prioritise, and integrate investments and multisectoral actions that influence health. In this paper, we call for greater coordination and coherence using a UHC+ lens to suggest new approaches to funding that can extend beyond biomedical health services to include the cross-cutting determinants of health. The proposed intersectoral co-financing mechanisms aim to support the advancement of health for all, regardless of countries' income.

Identifiants

pubmed: 37973345
pii: S2214-109X(23)00489-8
doi: 10.1016/S2214-109X(23)00489-8
pmc: PMC10664822
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1978-e1985

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

Copyright © 2023 World Health Organization. Published by Elsevier Ltd. All rights reserved. This is an Open Access article published under the CC BY-NC-ND 3.0 IGO license which permits users to download and share the article for non-commercial purposes, so long as the article is reproduced in the whole without changes, and provided the original source is properly cited. This article shall not be used or reproduced in association with the promotion of commercial products, services or any entity. There should be no suggestion that WHO endorses any specific organisation, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.

Déclaration de conflit d'intérêts

Declaration of interests We declare no competing interests.

Références

Lancet. 2020 Oct 17;396(10258):1135-1159
pubmed: 33069324
BMJ Glob Health. 2017 Aug 19;2(3):e000295
pubmed: 29082005
Lancet. 2017 Mar 4;389(10072):951-963
pubmed: 28271846
Health Aff (Millwood). 2002 Mar-Apr;21(2):78-93
pubmed: 11900188
Lancet Glob Health. 2020 Jan;8(1):e39-e49
pubmed: 31837954
BMJ. 2018 Jan 23;360:k125
pubmed: 29363500
BMJ Glob Health. 2019 Aug 18;4(4):e001717
pubmed: 31478015
Lancet. 2020 Oct 3;396(10256):991-1044
pubmed: 32941823
Lancet Glob Health. 2017 Jul;5(7):e720-e726
pubmed: 28619230
Glob Health Res Policy. 2021 Mar 1;6(1):8
pubmed: 33641673
Lancet. 2022 Mar 26;399(10331):1266-1278
pubmed: 35339227
Lancet. 2008 Nov 8;372(9650):1661-9
pubmed: 18994664
BMC Health Serv Res. 2018 Jan 30;18(1):54
pubmed: 29378655
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
Lancet. 2023 Jun 10;401(10392):1964-2012
pubmed: 37224836
BMJ Glob Health. 2016 Nov 24;1(3):e000068
pubmed: 28588955
Int J Epidemiol. 2013 Feb;42(1):221-7
pubmed: 23064501
Lancet. 2018 Oct 20;392(10156):1434-1460
pubmed: 30343859
World J Diabetes. 2017 Dec 15;8(12):489-511
pubmed: 29290922
PLoS One. 2016 Jan 19;11(1):e0144908
pubmed: 26783759
PLoS Med. 2022 Jan 13;19(1):e1003873
pubmed: 35025880
Lancet. 2020 5-11 Sep;396(10252):693-724
pubmed: 32334655
BMJ. 2019 Jul 31;366:l4499
pubmed: 31366599
Health Policy Plan. 2013 Jan;28(1):41-50
pubmed: 22407017

Auteurs

Téa E Collins (TE)

WHO Global NCD Platform, Geneva, Switzerland. Electronic address: collinst@who.it.

Svetlana Akselrod (S)

WHO Global NCD Platform, Geneva, Switzerland.

Rifat Atun (R)

Department of Global Health and Population, T H Chan School of Public Health, Boston, MA, USA.

Sara Bennett (S)

Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.

Osondu Ogbuoji (O)

Duke Global Health Institute, Duke University, Durham, NC, USA.

Mark Hanson (M)

Institute of Development Sciences, University of Southampton, Southampton, UK.

Grace Dubois (G)

NCD Alliance, Geneva, Switzerland.

Ani Shakarishvili (A)

Joint UN Programme on HIV/AIDS, Geneva, Switzerland.

Ilze Kalnina (I)

Partnership for Maternal, Newborn, and Child Health, Geneva, Switzerland.

Jennifer Requejo (J)

Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.

Andrei Mosneaga (A)

Stop TB Partnership, Geneva, Switzerland.

Akihito Watabe (A)

INSEAD, Manila, Philippines.

Daria Berlina (D)

WHO Global NCD Platform, Geneva, Switzerland.

Luke N Allen (LN)

WHO Global NCD Platform, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH